Accredited Drug Testing offers comprehensive hair follicle drug assessments in Freeport, Michigan. Should a hair drug or alcohol evaluation be required, our specialization in hair testing is complemented by numerous centers nationwide available for these services. A minimum of 1.5 to 2 inches of hair from the crown or body is typically needed. Hair evaluations can detect drugs, alcohol/ETG, or can be customized for other analyses.
Over recent years, drug testing practices have increasingly incorporated hair follicle assessment. Numerous employers, judicial systems, and substance abuse experts now favor hair tests over traditional urine analyses. Employers with stringent no-drug policies, courts, and individuals on probation often employ hair evaluations. The key advantage is a longer detection window, generally up to 90 days, implemented through an observed procedure making it nearly impossible to alter. Nevertheless, for recent drug use detection, urine tests are still the most accurate.
* You must register by phone or online to receive your donor pass/registration prior to proceeding to the testing center. You must bring a valid government issued ID along with the registration/barcode number which was sent to you by email.
When you're searching for hair drug testing near me or hair drug testing locations, we provide a simple and convenient process to find a drug and alcohol testing location near you that is certified to provide all of your drug and alcohol testing needs.
Hair testing has emerged as an influential means for identifying drug and alcohol consumption. By embedding biomarkers within its fibers, hair can present an extended timeline of alcohol and drug utilization. When collected near the scalp, it can offer a detection span of roughly 3 months for alcohol and drugs. Gathering hair is straightforward, somewhat resistant to tampering, and convenient for shipping.
A specimen of 1.5 inches with about 200 hair strands (roughly the width of a #2 pencil) nearest the scalp yields 100mg, an optimal quantity for both screening and confirmation. For EtG, add-ons, and/or panels exceeding 10, a specimen of 150mg is advised. We advocate using a jeweler’s scale for weighing the sample. In cases where scalp hair is absent, a comparable quantity of body hair might be used. By head hair, we mean scalp hair exclusively, whereas body hair includes all other types (such as facial and axillary).
Process Overview
Four primary steps constitute the lab processing of a drug test result: Accessioning, Screening, Extraction, and Confirmation.
Accessioning is the initial phase where a sample is introduced into a lab's system. It entails confirming proper sealing and shipping of the sample, assigning a random LAN (Laboratory Accessioning Number), and completing any outstanding data entry absent from an electronic chain of custody framework.
Screening features an initial swift assessment for substance abuse. While it offers a cost-effective method to eliminate drug usage in most samples, any positive screen requires confirmation to become court-admissible. Presumptively positive samples in Screening necessitate a secondary verification.
For samples flagged as presumptive positives in the Screening phase, further hair is sourced from the initial specimen and arranged for Extraction. In this step, substances are isolated from hair at lower concentrations compared to other methods (e.g., urine or oral fluid), hence making hair drug screening the most challenging technique to execute.
Confirmation of any positive screening outcome is performed using GC/MS, GC/MS/MS, or LC/MS/MS. All presumptive positive specimens undergo washing before confirmation if required. The entire laboratory process, from Accessioning to Confirmation, is inspected under both the CAP (College of American Pathologists) Hair certification and compliance with ISO / IEC 17025 standards.
Advantages of hair drug testing:
Limitations:
Note: Although commonly termed "hair follicle tests", the assessment examines the hair strand itself and not the follicle beneath the scalp
In Freeport, MI, hair follicle testing is favored over urine tests due to its superior accuracy and dependability. Unlike urine testing, hair samples can reveal drug use over a much longer period, delivering a broader historical perspective. This provides clear advantages for employers who require thorough evaluations.
Employers in Freeport, MI, benefit from hair follicle testing owing to its extended detection capability, covering up to 90 days of drug history. This wider window grants employers an extensive view of an individual's substance habits, aiding in a more informed assessment.
The hair follicle testing method in Freeport, MI, exhibits a high resistance to tampering. Unlike other testing methods, hair samples are less likely to be adulterated, ensuring their validity and reliability.
With convenient testing facilities both locally in Freeport, MI, and nationwide, hair follicle testing is easily accessible. Users can quickly access centers, reducing wait times and ensuring a streamlined testing experience.
In Freeport, MI, the hair follicle testing process is designed to be straightforward and confidential. Users can confidently navigate the simple steps from ordering a test to receiving results, with privacy being a central concern.
With competitive pricing and fast turnaround times, Freeport, MI, offers hair follicle testing solutions that cater to businesses of all sizes needing quick results. This makes it a cost-effective choice for companies seeking value without compromising on accuracy.
Hair follicle tests in Freeport, MI, represent exceptional speed and precision. They offer an unmatched level of accuracy in determining substance use, ensuring that results are both fast and reliable. The advanced technology in hair testing allows for quick results without sacrificing accuracy.
Hair follicle testing in Freeport, MI, offers employers assurance and compliance with workplace drug policies. The use of this testing method minimizes legal risks and promotes a safer work environment by ensuring the integrity of drug-use data.
